Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Minerva Neurosciences (NERV) Total Non-Current Liabilities (2017 - 2026)

Minerva Neurosciences filings provide 1 years of Total Non-Current Liabilities readings, the most recent being $2.8 million for Q4 2021.

  • On a quarterly basis, Total Non-Current Liabilities changed N/A to $2.8 million in Q4 2021 year-over-year; TTM through Dec 2021 was $2.8 million, a N/A change, with the full-year FY2021 number at $2.8 million, changed N/A from a year prior.
  • Total Non-Current Liabilities hit $2.8 million in Q4 2021 for Minerva Neurosciences, down from $4.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $6.2 million in Q2 2021 to a low of $2.8 million in Q4 2021.